Grape juice attenuates left ventricular hypertrophy in dyslipidemic mice.

作者: Ângela Maria Martins , Danielle Aparecida Quintino Silva Sarto , Karine de Paula Caproni , Janaína Silva , Jaqueline Silva

DOI: 10.1371/JOURNAL.PONE.0238163

关键词: MedicineDyslipidemiaInsulin resistanceLipid profileSimvastatinInsulinEndocrinologyLeft ventricular hypertrophyCholesterolInternal medicineHigh cholesterol

摘要: Objective We evaluated the effects of grape juice (Vitis labrusca L.) on dyslipidemia, resistance to insulin, and left ventricular hypertrophy (LVH) in mice homozygous for absence LDL receptor gene (LDLr -/-) under a hyperlipidemic diet. Methodology divided 30 male (3 months old) into three groups (n = 10); HL group was fed high-fat diet, HLU received diet 2 g/kg/day juice, HLS simvastatin (20 mg/kg/day). assessed blood pressure profile mice. also determined levels C-reactive protein (CRP) lipid profile, glycemic insulinemic profiles, calculated HOMA-IR. Cardiomyocyte hypertrophy, interstitial collagen deposit, expression CD40 ligand (CD40L) metalloproteinases 9 were immunohistologically. Results After 60 days, treated with showed similar results as those simvastatin. The use fruit attenuated dyslipidemia insulin significantly increased high cholesterol density lipoproteins (HDLc). antioxidant potential phenolic compounds associated increase HDLc prevented development LVH arterial hypertension since it inhibited inflammatory response induced by pathway its CD40L. Consequently, there lower MMP-2 MMP-9 serum CRP. Conclusion Grape has hypolipidemic cardiac protective potential, presenting effect that through direct action compounds, or indirectly, via anti-inflammatory activity HDLc. These suggest is functional food possessing prevent cardiovascular diseases.

参考文章(54)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
Julie CHRISTISON, Ari KARJALAINEN, Julie BRAUMAN, Fyfe BYGRAVE, Roland STOCKER, Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ. Biochemical Journal. ,vol. 314, pp. 739- 742 ,(1996) , 10.1042/BJ3140739
Ernst J Schaefer, Lipoproteins, nutrition, and heart disease The American Journal of Clinical Nutrition. ,vol. 75, pp. 191- 212 ,(2002) , 10.1093/AJCN/75.2.191
Yun You Li, Charles F McTiernan, Arthur M Feldman, Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovascular Research. ,vol. 46, pp. 214- 224 ,(2000) , 10.1016/S0008-6363(00)00003-1
Satoshi Genda, Tetsuji Miura, Takayuki Miki, Yoshihiko Ichikawa, Kazuaki Shimamoto, KATP channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia Journal of the American College of Cardiology. ,vol. 40, pp. 1339- 1346 ,(2002) , 10.1016/S0735-1097(02)02156-3
CM Gelbmann, SN Leeb, D Vogl, M Maendel, H Herfarth, J Schölmerich, W Falk, G Rogler, Inducible CD40 expression mediates NFκB activation and cytokine secretion in human colonic fibroblasts Gut. ,vol. 52, pp. 1448- 1456 ,(2003) , 10.1136/GUT.52.10.1448
H. T. Xavier, M. C. Izar, J. R. Faria Neto, M. H. Assad, V. Z. Rocha, A. C. Sposito, F. A. Fonseca, J. E. dos Santos, R. D. Santos, M. C. Bertolami, A. A. Faludi, T. L. R. Martinez, J. Diament, A. Guimarães, N. A. Forti, E. Moriguchi, A. C. P. Chagas, O. R. Coelho, J. A. F. Ramires, , V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose Arquivos Brasileiros De Cardiologia. ,vol. 101, pp. 1- 20 ,(2013) , 10.5935/ABC.2013S010
Murray Epstein, Vito M. Campese, Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function American Journal of Kidney Diseases. ,vol. 45, pp. 2- 14 ,(2005) , 10.1053/J.AJKD.2004.08.040
Victoria Polyakova, Ivo Loeffler, Stefan Hein, Shigeru Miyagawa, Izabela Piotrowska, Sebastian Dammer, Juha Risteli, Jutta Schaper, Sawa Kostin, Fibrosis in endstage human heart failure: Severe changes in collagen metabolism and MMP/TIMP profiles International Journal of Cardiology. ,vol. 151, pp. 18- 33 ,(2011) , 10.1016/J.IJCARD.2010.04.053